Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis

NCT05897294 is registered in ClinicalTrials.gov with TFF Pharmaceuticals, Inc. as lead sponsor.

NCT NCT05897294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05897294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis
Lead sponsor
TFF Pharmaceuticals, Inc.
Phase
Expanded access
Overall status
No longer available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allergic bronchopulmonary aspergillosis, anastomotic infection, aspergillus tracheobronchitis, chronic pulmonary aspergillosis, invasive pulmonary aspergillosis, pulmonary fungal infection